Prodromal Parkinson's Disease: What We Know and What We do Not Know
Prodromal Parkinson's Disease (PD) represents a critical phase preceding the clinical onset of the disease, characterized by subtle and often non-motor symptoms that precede the classic motor manifestations. Understanding this prodromal phase is essential for early diagnosis, intervention, and potentially altering the disease course. This narrative review aims to elucidate the current knowledge on the prodromal phase of PD, highlighting known biomarkers, genetic predispositions, and environmental factors that contribute to early detection. Furthermore, it examines the limitations and gaps in our understanding, including the variability in prodromal symptoms, challenges in identifying definitive biomarkers, and the need for longitudinal studies. By synthesizing the existing literature, this review provides a comprehensive overview of what we know about prodromal PD and underscores the areas that require further research to enhance early diagnostic accuracy and develop preventative strategies.
Authors
- Júlio César Claudino dos Santos (ORCID: https://orcid.org/0000-0001-6543-481X)
- Carolina Vieira Naia
- Luana Passos Oliveira (ORCID: https://orcid.org/0009-0003-4014-1334)
- Flávio de Lima Filho (ORCID: https://orcid.org/0009-0009-2100-0126)
- Giovana de Souza Faria
- A Dionisio
Institutions
- Centro Universitário Barão de Mauá (BR)
- Universitario Francisco de Asís (UY)
Publication Details
- Journal
- Brazilian Journal of Clinical Medicine and Review
- Published
- 2024-09-03
- DOI
- https://doi.org/10.52600/2965-0968.bjcmr.2025.3.1.bjcmr13
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00